| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/31/2006 | CA2375362C Electroporation cell with arc prevention or reduction |
| 10/31/2006 | CA2332183C Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (egf-r); diagnostic and therapeutic use |
| 10/31/2006 | CA2293819C A method for in vitro molecular evolution of protein function |
| 10/31/2006 | CA2256545C Probe for analysis of nucleic acids |
| 10/31/2006 | CA2250047C Monoclonal antibodies binding human growth hormone (hgh) |
| 10/31/2006 | CA2239729C Cell separation composition, kit and method |
| 10/31/2006 | CA2236925C Microencapsulated dna for vaccination and gene therapy |
| 10/31/2006 | CA2180830C Anti-annexin-v monoclonal antibody, process for producing the same, and use thereof |
| 10/31/2006 | CA2179012C Molecular diagnosis of familial adenomatous polyposis |
| 10/31/2006 | CA2173862C Apparatus and method for transfer of a fluid sample |
| 10/31/2006 | CA2162677C Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds |
| 10/31/2006 | CA2148482C Deblocking the common pathway of aromatic amino acid synthesis |
| 10/31/2006 | CA2129733C Mammalian expression systems for hcv proteins |
| 10/26/2006 | WO2006113743A2 Compositions and methods for rna interference with sialidase expression and uses thereof |
| 10/26/2006 | WO2006113559A2 Methods for modulating bone formation and mineralization by modulating krc activity |
| 10/26/2006 | WO2006113534A1 Immortilization of cells including neuronal cells |
| 10/26/2006 | WO2006113487A1 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 10/26/2006 | WO2006113481A1 Secondary metabolite production via manipulation of genome methylation |
| 10/26/2006 | WO2006113372A2 Porcine circovirus and helicobacter combination vaccines |
| 10/26/2006 | WO2006113277A2 Multivalent soluble tyrokinase receptor that bind angiogenic factor |
| 10/26/2006 | WO2006113214A2 Vaccine against pandemic strains of influenza viruses |
| 10/26/2006 | WO2006113139A2 Method of altering the binding specificity of proteins by oxidation-reduction reactions |
| 10/26/2006 | WO2006113085A2 D-amino acid dehydrogenase and method of making d-amino acids |
| 10/26/2006 | WO2006112929A2 The hiv gp-41-membrane proximal region arrayed on hepatitis b surface antigen particles as novel antigens |
| 10/26/2006 | WO2006112869A2 Modulation of cytokine signaling regulators and applications for immunotherapy |
| 10/26/2006 | WO2006112818A2 3' modified oligonucleotides containing pseudoisocytosine nucleobase derivatives and applications thereof as primers or probes |
| 10/26/2006 | WO2006112737A1 Vesiculins |
| 10/26/2006 | WO2006112705A2 Modulation of exon recognition in pre-mrna by interfering with the binding of sr proteins and by interfering with secondary rna structure. |
| 10/26/2006 | WO2006112513A1 Method and composition to evaluate cytochrome p450 2d6 isoenzyme activity using a breath test |
| 10/26/2006 | WO2006112456A1 Perkinson disease-related gene grk5 and use thereof |
| 10/26/2006 | WO2006112449A1 NOVEL NON-HUMAN ANIMAL MODEL FOR ALZHEIMER'S DISEASE HAVING DETERIORATED A-β EXCRETION FUNCTION |
| 10/26/2006 | WO2006112418A1 Screening system for substance inhibiting inflammatory change of adipocyte and screening method using the same |
| 10/26/2006 | WO2006112401A1 Composition for treatment of cancer |
| 10/26/2006 | WO2006112400A1 Method of examining metastatic property and infiltration ability of cancer |
| 10/26/2006 | WO2006112327A1 Lk3 gene regulating rice grain length and the use thereof |
| 10/26/2006 | WO2006112253A1 NOVEL β-GALACTOSIDE-α2,3-SIALYLTRANSFERASE, GENE ENCODING THE SAME, AND PROCESS FOR PRODUCTION OF THE SAME |
| 10/26/2006 | WO2006112239A1 hTERT GENE EXPRESSION REGULATORY GENE |
| 10/26/2006 | WO2006112238A1 Gene capable of controlling differentiation/growth of plant, and use of the same |
| 10/26/2006 | WO2006112147A1 Transgenic bird producing erythropoietin and method of constructing the same |
| 10/26/2006 | WO2006112141A1 Method of base determination and base determination kit |
| 10/26/2006 | WO2006112034A1 Method of construcing transgenic ice plant |
| 10/26/2006 | WO2006112025A1 NOVEL β-GALACTOSIDE-α-2,3-SIALYLTRANSFERASE, GENE ENCODING THE SAME AND METHOD FOR PRODUCING THE SAME |
| 10/26/2006 | WO2006112000A1 Method of synthesizing 2-deoxy-scyllo-inosose by modified strain of e. coli, method of purifying the same and obtained 2-deoxy-scyllo-inosose |
| 10/26/2006 | WO2006111998A1 Recombinant adenoviral vector for the expression of mdm family proteins and uses thereof |
| 10/26/2006 | WO2006111982A1 A process for producing modified reconstituted sendai viral envelope specific for drug and/or gene delivery to liver cells |
| 10/26/2006 | WO2006111757A2 Animal model of vascular smooth muscle cell apoptosis |
| 10/26/2006 | WO2006111745A2 Composition and method for treating viral infection |
| 10/26/2006 | WO2006111541A2 Expression cassettes for seed-preferential expression in plants |
| 10/26/2006 | WO2006111512A1 Improved methods controlling gene expression |
| 10/26/2006 | WO2006111372A2 Phytase |
| 10/26/2006 | WO2006111029A1 Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers |
| 10/26/2006 | WO2006110950A1 In vivo model for preclinical drug development |
| 10/26/2006 | WO2006092738A8 Micrornas and related nucleic acids |
| 10/26/2006 | WO2006084953A9 Novel microbial enzymes and their use |
| 10/26/2006 | WO2006084714A9 Novel gene sts 18 |
| 10/26/2006 | WO2006083984A9 Papillomavirus l2 n-terminal peptides for the induction of broadly cross-neutralizing antibodies |
| 10/26/2006 | WO2006079567A3 Brassica plant comprising a mutant fatty acid desaturase |
| 10/26/2006 | WO2006077152A3 Hla fusion molecules and uses thereof |
| 10/26/2006 | WO2006075996A3 Reporter plasmid phage packaging system for detection of bacteria |
| 10/26/2006 | WO2006069306A3 A knockout mouse for the tumor suppressor gene anx7 |
| 10/26/2006 | WO2006060598A3 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN AND INTERLEUKIN RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 10/26/2006 | WO2006055416A3 Transgenic mouse capable of over-expressing vascular endothelial protein tyrosine phosphatase (ve-ptp) |
| 10/26/2006 | WO2006041759A3 Transgenic frog lines and assays employing them |
| 10/26/2006 | WO2006034286A3 Isopentenyl transferase sequences and methods of use |
| 10/26/2006 | WO2006032916A3 A method for increasing seed size |
| 10/26/2006 | WO2006031779A3 Promoter molecules for use in plants |
| 10/26/2006 | WO2006022882A3 Canine pancreatic lipse |
| 10/26/2006 | WO2006019430B1 Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells |
| 10/26/2006 | WO2006017428A3 Use of magnetic material to direct isolation of compounds and fractionation of multipart samples |
| 10/26/2006 | WO2006015376A3 Monocot ahass sequences and methods of use |
| 10/26/2006 | WO2005106011A3 Process for preparing dipeptidyl iv inhibitors and intermediates therefor |
| 10/26/2006 | WO2005095625A8 Arabinogalactan protein compositions and methods for fostering somatic embryogenic competence |
| 10/26/2006 | WO2005086938A3 Artificial mutation controls for diagnostic testing |
| 10/26/2006 | WO2005056578A9 High-level expression of fusion polypeptides in plant seeds utilizing seed-storage proteins as fusion carriers |
| 10/26/2006 | WO2005054427A3 Target sequences for synthetic molecules |
| 10/26/2006 | WO2005042708A3 METHOD OF DESIGNING siRNAS FOR GENE SILENCING |
| 10/26/2006 | WO2005035719A3 Modified luciferase |
| 10/26/2006 | WO2005020888A3 Compositions and methods of treating and diagnosing hepatoma |
| 10/26/2006 | WO2004071168A3 Nucleic acids encoding anthelmintic agents and plants made therefrom |
| 10/26/2006 | WO2003093789A3 Method for measuring ion channel activity |
| 10/26/2006 | WO2002101008A3 Intracellular signaling molecules |
| 10/26/2006 | WO2002090522A3 Use of phosphorothiolate polynucleotides in ligating nucleic acids |
| 10/26/2006 | WO2002078420A3 Molecules for disease detection and treatment |
| 10/26/2006 | US20060242739 Plant nucleotide-sugar pyrophosphatase/phosphodiesterase (nppase), method of obtaining same and use of same in the production of assay devices and in the production of transgenic plants |
| 10/26/2006 | US20060242738 Polynucleotides and polypeptides in plants |
| 10/26/2006 | US20060242737 Modulation of flowering time by the pft1 locus |
| 10/26/2006 | US20060242736 Dissimilar promoters for gene suppression |
| 10/26/2006 | US20060242735 Nucleic acid fragments encoding isoflavone synthase |
| 10/26/2006 | US20060242734 Insecticidal polypeptides and methods of use thereof |
| 10/26/2006 | US20060242733 transformed plant comprising in its genome a stably incorporated nucleotide construct containing a nucleotide sequence that encodes a polypeptide that is pesticidal for pest belonging to the order Lepidoptera, coding sequence is operably linked to a promoter that drive expression in a plant cell |
| 10/26/2006 | US20060242732 encode pesticidal proteins; transgenic pest resistant plants |
| 10/26/2006 | US20060242731 DNA shuffling to produce herbicide selective crops |
| 10/26/2006 | US20060242730 Methods and compositions for tobacco plants with reduced nitrosamines |
| 10/26/2006 | US20060242729 Polynucleotides encoding proteins involved in plant metabolism |
| 10/26/2006 | US20060242728 Chemically-inducible promotors for the expression of proteins in plants |
| 10/26/2006 | US20060242727 Expression cassette encoding a 5-enolpyruvylshikimate-3-phosphate synthase (epsps) and herbicde-tolerant plants containing it |
| 10/26/2006 | US20060242726 Methods and vectors for making knockout animals |
| 10/26/2006 | US20060242724 Receptor |
| 10/26/2006 | US20060242723 Chimeric mouse with regulated bradeion gene expression |
| 10/26/2006 | US20060242722 Genetic manipulation of nonhuman animals to be used for xenotransplantation; null swine; obtaining a line of cells from a GGTA1 heterozygous swine, enriching them by treatment with agents that specifically bind alpha (1,3)-galactose epitope and deplete cells that do not, scanning for viable cells |